NCT04879953
- Conditions
- Abdominal Neoplasms, Carcinomatosis, Peritoneal, Digestive System Diseases, +5 more
- Locations
-
- CHUGA Grenoble, France
Clinical trial condition
Peritoneal Neoplasms
Explore clinical trials studying Peritoneal Neoplasms. Study availability and eligibility vary by location and protocol.
179 public trials
41 recruiting studies
Peritoneal Neoplasms trial results
NCT03561948
- Conditions
- Abdominal Neoplasms, Colon Cancer, Colonic Diseases, +12 more
- Locations
-
- State Scientific Centre of Coloproctology Moscow, Russia
NCT03593681
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Adnexal Mass, +26 more
- Locations
-
- Scripps Clinic Medical Group San Diego, California, United States
- Kaiser Permanente San Francisco Medical Center San Francisco, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
Completed
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
NCT00262990
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
- Locations
-
- Alaska Cancer Research & Education Center Anchorage, Alaska, United States
- Northern Arizona Hematology & Oncology Associates Flagstaff, Arizona, United States
- Mayo Center for Women's Health Scottsdale, Arizona, United States
- Northern Arizona Hematology & Oncology Associates Sedona, Arizona, United States
NCT00216372
- Conditions
- Abdominal Neoplasms, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- Clinique Universitaire St. LUC Brussels, Belgium
- Institut Jules Bordet Brussels, Belgium
- Clinique Notre-Dame Hermalle-sous-Huy, Belgium
- Centre Hospitalier de Jolimont-Lobbes La Louvière, Belgium
NCT02784028
- Conditions
- Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +5 more
- Locations
-
- Institut régional du Cancer de Montpellier Montpellier, France
NCT03364907
- Conditions
- Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- Radboudumc Nijmegen, Netherlands
NCT00391118
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liège, Belgium
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Düsseldorf, Germany
- Conditions
- Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +5 more
- Locations
-
- Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment Candiolo, Turin, Italy
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea